Income Taxes - Summary of Deferred Tax Assets (Details) - USD ($) $ in Thousands |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Income Tax Disclosure [Abstract] | ||
Net operating loss carryforwards | $ 30,093 | $ 5,087 |
Net research and development expenditures | 10,656 | 7,478 |
Share issuance costs | 3,538 | 4,506 |
Net federal investment tax credits | 4,805 | 3,181 |
U.S. research and development tax credits | 1,775 | 961 |
Tax basis of property and equipment in excess of carrying values | (86) | |
Operating lease right-of-use assets | (1,995) | (1,240) |
Operating lease liability | 1,950 | 1,063 |
Accrued expense and other liabilities | 760 | 345 |
Deferred revenue | 13,656 | 15,372 |
Share-based compensation | 988 | 103 |
Total deferred tax assets | 66,226 | 36,770 |
Valuation allowance | (62,606) | (35,358) |
Net deferred tax assets | $ 3,620 | $ 1,412 |
X | ||||||||||
- Definition Deferred tax assets net federal investment tax credits. No definition available.
|
X | ||||||||||
- Definition Deferred tax assets operating lease right-of-use assets. No definition available.
|
X | ||||||||||
- Definition Deferred tax assets share based compensation cost. No definition available.
|
X | ||||||||||
- Definition Deferred tax liabilities accrued expense and other liabilities. No definition available.
|
X | ||||||||||
- Definition Deferred tax liabilities operating lease liability. No definition available.
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment. No definition available.
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|